{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/634549cdd950350012c90fc5/68b812b8a742b7c8461c99d8?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Guideline adherence in the management of lupus: Key challenges and potential solutions ","description":"<p>During the Lupus Hub Steering Committee (SC) Meeting held on June 19, 2025, key opinion leaders convened to discuss the key challenges associated with implementing guidelines for <a href=\"https://lupushub.com/types/systemic-lupus-erythematosus\" rel=\"noopener noreferrer\" target=\"_blank\">systemic lupus erythematosus</a> (SLE) and <a href=\"https://lupushub.com/types/lupus-nephritis\" rel=\"noopener noreferrer\" target=\"_blank\">lupus nephritis</a> (LN) in clinical practice, as well as potential solutions. The meeting commenced with a presentation by the Lupus Hub SC Chair Ricard Cervera, who provided an overview of the key international guidelines, including <a href=\"https://lupushub.com/medical-information/management-of-systemic-lupus-erythematosus-and-lupus-nephritis-updated-2023-recommendations-from-eular\" rel=\"noopener noreferrer\" target=\"_blank\">the 2023 EULAR recommendations for SLE and LN</a>, <a href=\"https://lupushub.com/medical-information/management-of-lupus-nephritis-acr-2024-guidelines\" rel=\"noopener noreferrer\" target=\"_blank\">the 2024 ACR guidelines for LN</a>, <a href=\"https://lupushub.com/medical-information/2025-american-college-of-rheumatology-guidelines-for-the-treatment-of-sle\" rel=\"noopener noreferrer\" target=\"_blank\">the 2025 ACR guidelines for SLE</a>, <a href=\"https://lupushub.com/medical-information/management-of-lupus-nephritis-kdigo-2024-clinical-practice-guidelines\" rel=\"noopener noreferrer\" target=\"_blank\">the 2024 KDIGO guidelines for LN</a>, and <a href=\"https://lupushub.com/medical-information/non-pharmacological-management-of-patients-with-systemic-lupus-erythematosus-eular-recommendations\" rel=\"noopener noreferrer\" target=\"_blank\">the 2023 EULAR guidelines for non-pharmacological management of SLE</a>, and the need for a multidisciplinary approach to implement the guidelines in practice. The discussion featured other SC members (rheumatologists and immunologists), including <a href=\"https://lupushub.com/contributors/betty-diamond\" rel=\"noopener noreferrer\" target=\"_blank\">Betty Diamond</a>, <a href=\"https://lupushub.com/contributors/gaurav-gulati\" rel=\"noopener noreferrer\" target=\"_blank\">Gaurav Gulati</a>, <a href=\"https://lupushub.com/contributors/dr\" rel=\"noopener noreferrer\" target=\"_blank\">Ioannis Parodis</a>, <a href=\"https://lupushub.com/contributors/jill-buyon\" rel=\"noopener noreferrer\" target=\"_blank\">Jill Buyon</a>, <a href=\"https://lupushub.com/contributors/laurent-arnaud\" rel=\"noopener noreferrer\" target=\"_blank\">Laurent Arnaud</a>, and <a href=\"https://lupushub.com/contributors/manuel-francisco-ugarte-gil\" rel=\"noopener noreferrer\" target=\"_blank\">Manuel Francisco Ugarte-Gil</a>, and four invited guest speakers – David D’Cruz (rheumatologist and thrombosis expert), David Jayne (nephrologist), Nathalie Costedoat-Chalumeau (autoimmune disease expert), and Onno Teng (nephrologist). Together, this multidisciplinary panel explored key barriers to the clinical implementation of guidelines and practical strategies to improve guideline adherence in routine settings.&nbsp;&nbsp;</p><p><br></p><p><em>This independent educational activity was supported by AstraZeneca. All content was developed independently. The funder was allowed no influence on the content of this activity.</em></p>","author_name":"Scientific Education Support"}